SEC Form 3 · accession 0001524679-15-000002
PDL BIOPHARMA, INC. · PDLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
May 17, 2015
Accepted (ET)
Jun 24, 2015 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| PDL Stock | holding | — | — | — | 1 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Initial ownership of PDL one share by Immune Response BioPharma, Inc.